FDA greenlights Novavax’s COVID-19 vaccine, adding unique option to U.S. arsenal
By
Alicia Lasek (f3)
Jul 14, 2022
The FDA late Wednesday authorized Novavax’s adjuvanted COVID-19 vaccine for emergency use in adults aged 18 years and older.
FDA advisers vote unanimously to endorse Novavax’s COVID-19 vaccine
By
Alicia Lasek (f3)
Jun 08, 2022
Independent advisers have voted 21 to 0 to recommend the authorization of Novavax’s COVID-19 protein-based vaccine for pandemic emergency use.
Vaccines highly effective against severe omicron illness, CDC research assures
By
Alicia Lasek
Mar 22, 2022
Two or three COVID-19 vaccine doses provided 90% protection against invasive mechanical ventilation or in-hospital death during both the delta and omicron periods, according to new CDC data.
Unvaccinated have highest SARS-CoV-2 incidence, hospitalization
Feb 02, 2022
COVID-19 incidence and hospitalization rates are consistently higher for unvaccinated persons, and lowest for those fully vaccinated with a booster, according to research published Monday by the CDC.
HHS to LTC operators: Step up your booster clinic timelines before year ends
By
Alicia Lasek
Dec 22, 2021
Long-term care operators should speed up plans to help residents boost their immunity before an expected COVID-19 surge hits, a federal official told virtual town hall attendees Tuesday.
CDC: Boosted nursing home residents 10 times less likely to be infected with COVID-19
By
Alicia Lasek
Dec 17, 2021
The news, delivered by CDC Director Rochelle Walensky, is a bit of cheer amidst other new evidence that COVID-19 cases are increasing among fully vaccinated long-term care residents.
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.
COVID shot boosters for all adults will help to reduce confusion, FDA says
By
Alicia Lasek
Nov 22, 2021
The FDA “heard loud and clear” that a simpler booster strategy was needed, its vaccine chief says. But the action may be too late to head off a winter virus surge, observers say.
‘How good are those vaccines now?’ Mixed AARP nursing home report prompts a thorny question
By
Alicia Lasek
Nov 15, 2021
A new AARP report shows encouraging trends in COVID-19 cases and vaccinations. But the steady rate of resident deaths raises concerns for the future as vaccine efficacy wanes, analysts say.
Pfizer-BioNTech vaccine highly effective in octo- and nonagenarians, German study finds
By
Alicia Lasek
Nov 10, 2021
The data, from 700,000 older residents of Bavaria, resolves questions about the vaccine’s protectiveness that weren’t answered by the drugmaker’s clinical trials, investigators say.